Generation and validation of CRISPR-engineered human natural killer cell lines for research and therapeutic applications

por Kumar, Anil, Lee, Sung June, Liu, Qiao, Chan, Anthony K.N., Pokharel, Sheela Pangeni, Yu, Jianhua, Chen, Chun-Wei, Swaminathan, Srividya
Publicado 2021

Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia

por Duault, Caroline, Kumar, Anil, Taghi Khani, Adeleh, Lee, Sung June, Yang, Lu, Huang, Min, Hurtz, Christian, Manning, Bryan, Ghoda, Lucy, McDonald, Tinisha, Lacayo, Norman J., Sakamoto, Kathleen M., Carroll, Martin, Tasian, Sarah K., Marcucci, Guido, Yu, Jianhua, Caligiuri, Michael A., Maecker, Holden T., Swaminathan, Srividya
Publicado 2021

Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms

por Taghi Khani, Adeleh, Kumar, Anil, Sanchez Ortiz, Ashly, Radecki, Kelly C., Aramburo, Soraya, Lee, Sung June, Hu, Zunsong, Damirchi, Behzad, Lorenson, Mary Y., Wu, Xiwei, Gu, Zhaohui, Stohl, William, Sanz, Ignacio, Meffre, Eric, Müschen, Markus, Forman, Stephen J., Koff, Jean L., Walker, Ameae M., Swaminathan, Srividya
Publicado 2023

Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia

por Kumar, Anil, Taghi Khani, Adeleh, Duault, Caroline, Aramburo, Soraya, Sanchez Ortiz, Ashly, Lee, Sung June, Chan, Anthony, McDonald, Tinisha, Huang, Min, Lacayo, Norman J., Sakamoto, Kathleen M., Yu, Jianhua, Hurtz, Christian, Carroll, Martin, Tasian, Sarah K., Ghoda, Lucy, Marcucci, Guido, Gu, Zhaohui, Rosen, Steven T., Armenian, Saro, Izraeli, Shai, Chen, Chun-Wei, Caligiuri, Michael A., Forman, Stephen J., Maecker, Holden T., Swaminathan, Srividya
Publicado 2023